Epileptic Seizure Monitor Alarm System Market Size, Share & Trends Analysis Report By Product (Bed Sensor & Wearable Devices), By Applications (Online, Offline), By End Use, By Region, and Segment Forecasts - 2035

Epileptic Seizure Monitor Alarm System Market Overview

epileptic seizure monitor alarm system market size was valued at USD 24.53 million in 2025 and is poised to grow from USD 27.87 million in 2026 to USD 40.85 million by 2035, growing at a CAGR of 13.6% during the forecast period (2026-2035).

The Epileptic Seizure Monitor Alarm System Market is developing rapidly as families, healthcare providers, residential care organizations, and patients adopt technologies designed to support continuous seizure monitoring and faster caregiver notification. Wearable Devices account for an estimated 59% of current demand, while Bed Sensor systems represent approximately 41%. Online channels account for approximately 57% of product distribution, compared with 43% for Offline channels through healthcare suppliers, specialist retailers, care organizations, and medical equipment networks. More than 50 million people worldwide live with epilepsy, while approximately 5 million new cases are diagnosed each year, creating a substantial potential population for monitoring technologies. Current products range from contact-free under-mattress movement sensors to wrist-worn devices combining accelerometry and electrodermal activity. New-generation wearable systems can provide up to 7 days of battery life and have demonstrated approximately 98% detection accuracy for defined generalized tonic-clonic seizure monitoring under validated conditions. Product development is increasingly focused on continuous monitoring, smartphone connectivity, caregiver alerts, improved algorithms, and lower false-alarm frequency.

The United States represents the largest individual market for wearable seizure monitoring and is a major center for digital neurology innovation. North America accounts for an estimated 38% of global market demand, with the U.S. representing more than 80% of regional activity. FDA-cleared wrist-worn seizure monitoring technology is currently available for adults and children aged 6 years and older, increasing clinical confidence in connected home-monitoring solutions. Modern systems can combine a wearable device with a smartphone application that automatically initiates caregiver notifications after detecting patterns potentially associated with generalized tonic-clonic seizures. Products with approximately 7-day battery life reduce charging frequency compared with earlier-generation wearables and support more continuous observation. U.S. market development is also being influenced by telehealth, remote patient monitoring, caregiver applications, and direct-to-consumer digital purchasing, increasing the relevance of the Online channel for both device discovery and ongoing subscription-based services.

• 

  Download Free sample to learn more about this report.

Key Findings

• Leading Product Type: Wearable Devices are expected to lead with approximately 59% market share as wrist-worn systems increasingly combine motion sensing, physiological signals, smartphone connectivity, automatic caregiver alerts, and continuous monitoring capabilities.
• Leading Application: Online distribution is projected to account for approximately 57% of market demand as connected seizure-monitoring products increasingly use digital purchasing, smartphone applications, remote setup, subscription services, and direct caregiver support.
• Leading Region: North America is expected to hold approximately 38% market share, supported by advanced digital-health infrastructure, FDA-cleared wearable technology, telehealth adoption, high consumer awareness, and established remote-monitoring ecosystems.
• Fastest Growing Region: Asia-Pacific is projected to expand at approximately 16.2% annually as digital healthcare, smartphone penetration, neurological awareness, online medical-device distribution, and home-monitoring adoption increase across populous markets.
• Technology Trend: Multisensor wearable monitoring is reshaping the market, with current medical-grade systems demonstrating approximately 98% detection accuracy for defined generalized tonic-clonic seizure events under validated testing conditions.
• Market Driver: The large global epilepsy population remains the primary demand driver, with more than 50 million people living with epilepsy and approximately 5 million new diagnoses occurring worldwide each year.
• Competitive Landscape: Established bed-monitoring technology continues to retain relevance, with one specialist seizure-monitor product family surpassing 10,000 installed monitors after more than 25 years of development and clinical-support use.
• Future Outlook: Longer-duration wearable monitoring will support wider adoption as next-generation devices provide battery operation reaching approximately 7 days, reducing charging interruptions and supporting more consistent home-based observation.

Latest Trends

Wearable seizure-monitoring technology represents the most important current trend in the Epileptic Seizure Monitor Alarm System Market. New-generation devices are moving beyond simple movement detection by combining accelerometers with physiological sensors, smartphone applications, automated algorithms, cloud connectivity, and caregiver communication. Medical-grade wrist-worn systems can monitor electrodermal activity and motion continuously and can initiate an alert when patterns associated with generalized tonic-clonic seizures are detected. Current FDA-cleared technology supports adults and children aged 6 years and older and has demonstrated approximately 98% detection accuracy against hospital-based reference monitoring for defined seizure types. Battery duration has improved significantly, with selected devices providing up to 7 days of operation, making continuous monitoring more practical for everyday use. These capabilities support Wearable Devices, which account for an estimated 59% of market demand. Manufacturers are also improving smartphone interfaces so patients and caregivers can record seizures, sleep, physical activity, and manually triggered events within one connected monitoring environment.

Bed Sensor technologies are simultaneously becoming more sophisticated rather than disappearing as wearable adoption grows. Contact-free under-mattress products remain important for nighttime monitoring because users do not need to wear or recharge a device while sleeping. Modern systems can distinguish sustained abnormal bed movements from ordinary sleep activity and may integrate additional functions such as bed-vacation detection, sound monitoring, moisture sensing, and nurse-call connectivity. Selected professional systems can provide radio communication ranges approaching 450 meters and battery backup lasting approximately 15 hours, supporting institutional environments where continuous operation is important. Another widely used bed-monitoring product has accumulated more than 10,000 installations after approximately 25 years of product development. This continued adoption shows that the market is moving toward complementary rather than mutually exclusive technology models, with wearables providing mobility and continuous daily monitoring while Bed Sensor systems provide unobtrusive overnight surveillance.

Market Dynamics

Driver

""Growing demand for continuous seizure awareness is accelerating home-monitoring adoption.""

The global epilepsy burden is the primary structural driver for seizure monitoring technologies. More than 50 million people worldwide live with epilepsy, making it one of the most common neurological conditions. Approximately 5 million people are newly diagnosed each year, while active epilepsy affects an estimated 4 to 10 people per 1,000 population. Seizures can occur unpredictably and range from brief changes in awareness to prolonged convulsive events, creating demand for systems capable of notifying caregivers when assistance may be required. Monitoring is particularly relevant during sleep, when family members or caregivers may not directly observe a seizure. Bed Sensor systems address this environment through under-mattress movement detection, while Wearable Devices provide monitoring both during rest and, depending on the product's approved use, throughout broader periods of daily activity. The availability of 2 distinct product types enables manufacturers to address different user requirements instead of relying on a single monitoring approach.

Caregiver connectivity provides another important driver because seizure alarms are increasingly designed as communication systems rather than isolated sensors. Modern wearable platforms can connect to a smartphone and automatically initiate notifications to designated caregivers when a qualifying event is detected. Some systems combine automated alerts with manually triggered alerts, giving users 2 pathways to request assistance. Bed-based equipment similarly integrates with radio pagers, telecare platforms, or nurse-call infrastructure. Professional monitoring systems can communicate across distances approaching 450 meters in suitable environments, allowing caregivers to respond without remaining continuously within the same room. This functionality is important in residential care facilities, hospitals, schools, and family homes. Online distribution, accounting for approximately 57% of market activity, further improves access by allowing caregivers to research compatibility, purchase connected products, manage subscriptions, and receive product-support information remotely.

Restraint

""Detection limitations and false alarms continue to restrict universal device adoption.""

No seizure-monitoring technology detects every seizure type, creating an important restraint on market adoption. Epilepsy can involve dozens of clinical manifestations, including generalized tonic-clonic, focal, tonic, atonic, myoclonic, and other seizure patterns. A wearable designed to identify generalized tonic-clonic seizures through motion and electrodermal activity may not be validated for seizures that generate minimal movement or different physiological responses. Similarly, an under-mattress movement monitor optimized for repetitive clonic activity may not reliably identify episodes characterized primarily by stillness. Even advanced systems demonstrating approximately 98% detection accuracy for defined generalized tonic-clonic events should therefore be selected according to intended use rather than treated as universal epilepsy detectors. These limitations require patients, families, and healthcare professionals to understand exactly which event patterns a specific product is designed to monitor.

False alarms create another restraint because ordinary movements, exercise, sleep behaviors, environmental vibration, or physiological changes can resemble patterns associated with seizures. Bed-monitoring products commonly use sensitivity and duration thresholds to reduce unnecessary alarms. Selected systems are factory configured to trigger only after abnormal repetitive movement continues for approximately 15 seconds, helping distinguish short movements from sustained seizure-like activity. However, sensitivity settings must sometimes be adjusted for individual body size, mattress type, sleeping behavior, and seizure pattern. Wearables face similar challenges when separating convulsive activity from vigorous everyday movements. Excessive false alarms can create alarm fatigue among caregivers, while insufficient sensitivity can reduce confidence in the system. Manufacturers therefore need to balance detection sensitivity and specificity carefully rather than maximizing only one performance metric.

Opportunity

""Connected remote monitoring creates significant opportunities for digital epilepsy management.""

Remote digital monitoring represents one of the largest opportunities for the Epileptic Seizure Monitor Alarm System Market. Wearable Devices currently account for approximately 59% of demand and increasingly operate through smartphone-based ecosystems rather than standalone receivers. These platforms can combine seizure events with sleep and activity information, creating longitudinal records that users can review over weeks or months. A device operating for up to 7 days between charges can generate substantially more continuous data than systems requiring daily charging. Remote connectivity can also allow caregivers to receive alerts even when they are not in the same room as the monitored person. As telehealth adoption expands, seizure diaries and monitoring information can potentially support more informed clinical conversations, although devices remain supplementary monitoring tools rather than replacements for professional diagnosis or treatment.

Emerging economies provide another major opportunity because approximately 80% of people with epilepsy live in low- and middle-income countries. This represents nearly 40 million people within the global epilepsy population of more than 50 million. At the same time, a large treatment and monitoring gap remains in many of these regions. Smartphone penetration and e-commerce are expanding rapidly, giving connected medical-device companies a path to reach consumers without constructing extensive specialist retail networks. Asia-Pacific is consequently projected to expand at approximately 16.2% annually, outpacing more mature markets. Online distribution can be especially relevant because digital channels allow manufacturers to centralize education, software updates, multilingual product support, subscription management, and caregiver applications. Affordable wearable and bed-based products designed around widely available smartphones could significantly broaden the accessible user base.

Challenge

""Clinical validation and individualized seizure patterns make reliable monitoring technically demanding.""

The fundamental technical challenge is the biological diversity of epilepsy. Seizures differ substantially between patients and can change over time within the same individual. A movement pattern lasting 20 seconds in one patient may be clinically different from a similar movement in another. Device developers therefore need carefully designed validation studies comparing sensor output with established clinical reference methods. Newer medical-grade wearable technologies have demonstrated approximately 98% detection accuracy for defined generalized tonic-clonic seizures, but this performance does not automatically extend to every seizure phenotype. Algorithms must also maintain performance across different ages, skin characteristics, activity patterns, device positions, and home environments. Regulatory review can consequently require extensive testing of clinical performance, usability, cybersecurity, and software reliability.

Maintaining user adherence creates an additional challenge. A wearable provides no useful monitoring when it is removed for charging, forgotten, positioned incorrectly, or disconnected from the paired smartphone. Extending battery duration toward approximately 7 days helps reduce this problem, but users must still maintain connectivity and device placement. Bed Sensor systems avoid wearable adherence issues, but installation can vary according to mattress construction and bed configuration. Under-mattress sensors may need to be positioned approximately 50 centimeters from the upper end of the bed so the sensing area aligns with the user's torso. Double beds, pressure-relieving mattresses, adjustable beds, and unusually thick mattresses can require additional setup. Successful products therefore need not only accurate sensors but also clear installation procedures and reliable technical support.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

By Types

Bed Sensor: Bed Sensor systems account for approximately 41% of the Epileptic Seizure Monitor Alarm System Market and remain important for overnight monitoring in homes, residential care facilities, and healthcare environments. These products typically place a pressure, movement, vibration, or force-sensitive sensor under the mattress, allowing monitoring without attaching electronics directly to the user. Modern seizure bed monitors can detect repetitive movements associated with generalized tonic-clonic seizures while filtering normal sleeping activity. Selected products use default alarm delays of approximately 15 seconds of sustained abnormal movement and allow sensitivity adjustments according to the individual user. Professional systems can additionally integrate bed-vacation detection, sound sensors, moisture monitoring, telecare, and nurse-call connections. Radio communication can reach approximately 450 meters in suitable environments, while some systems include around 15 hours of backup battery operation. The segment remains particularly relevant to users whose highest monitoring priority is nocturnal seizure detection.

Wearable Devices: Wearable Devices represent approximately 59% of market share and are expected to maintain leadership through 2035 because they enable monitoring beyond the bed environment. Current systems use wrist-worn sensors connected to smartphone applications, allowing movement and physiological signals to be processed continuously. Medical-grade products can combine accelerometer and electrodermal activity data and have demonstrated approximately 98% detection accuracy for defined generalized tonic-clonic seizure events. Selected devices support adults and children aged 6 years and older and provide battery operation extending to approximately 7 days. Automated caregiver alerts, manual alert functions, event diaries, sleep tracking, and activity information are increasingly incorporated within the same application. Wearable development is also benefiting from improvements in wireless communication, miniaturized sensors, battery technology, cloud processing, and artificial intelligence.

By Applications

Online: Online distribution accounts for approximately 57% of the Epileptic Seizure Monitor Alarm System Market and is becoming increasingly important as wearable monitoring shifts toward software-connected purchasing models. Patients and caregivers can research device specifications, compare product capabilities, order hardware, download applications, manage subscriptions, and access digital support through the same ecosystem. Wearable Devices are particularly compatible with this channel because smartphone applications already form part of the monitoring architecture. A device providing approximately 7 days of battery life can be shipped directly to users and paired with existing smartphones, reducing dependence on specialist physical installation. Online channels also help manufacturers reach geographically dispersed epilepsy populations, including consumers outside major cities. Digital education remains essential because product limitations must be explained clearly to prevent users from assuming that one device detects every seizure type.

Offline: Offline distribution represents approximately 43% of market demand and remains important for Bed Sensor products, professional care systems, specialist medical equipment, and users requiring installation guidance. Healthcare providers, medical-equipment distributors, assistive-technology specialists, pharmacies, care facilities, and clinical organizations can help match a device to individual seizure patterns. Bed Sensor products may require adjustment for mattress characteristics, body position, sensitivity, pager range, and nurse-call integration. Professional systems with radio coverage approaching 450 meters and multiple sensor inputs are particularly suited to specialist installation channels. Offline distribution is also important where healthcare reimbursement, prescriptions, institutional procurement, or regulatory requirements influence device access. As a result, the market is expected to remain omnichannel rather than moving entirely toward direct online purchasing.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

North America

North America represents approximately 38% of global Epileptic Seizure Monitor Alarm System Market demand and remains the leading region because of high digital-health adoption, substantial neurological care infrastructure, medical-device availability, and consumer familiarity with wearable technology. The United States is the largest regional market and provides access to FDA-cleared wearable seizure-monitoring technology intended for adults and children aged 6 years and older. Connected smartphone applications are also well established, strengthening the Online distribution channel.

Technology adoption is increasingly oriented toward clinically validated wearables rather than general-purpose consumer watches. Medical-grade systems capable of detecting defined generalized tonic-clonic seizure patterns have demonstrated approximately 98% accuracy and can provide battery operation reaching 7 days. Bed-based monitoring also retains a significant installed base in North America, including contact-free systems distributed for nighttime monitoring. Strong broadband, smartphone ownership, telehealth infrastructure, and caregiver connectivity support continued regional demand through 2035.

Europe

Europe accounts for approximately 32% of global market demand and has a particularly strong specialist bed-monitoring and assistive-technology ecosystem. Finland, Denmark, Germany, the United Kingdom, and neighboring markets have longstanding expertise in movement sensors, nurse-call systems, telecare, and epilepsy-support devices. Among the supplied leading companies, Emfit originates from Finland, Alert-it and Danish Care are associated with Northern European care technology, and Vahlkamp maintains a European monitoring presence.

European Bed Sensor products demonstrate the maturity of this segment. Selected professional systems provide radio ranges up to approximately 450 meters, 15-hour backup batteries, and integration with nurse-call and telecare networks. Another monitoring platform can store approximately 20 seizure-event messages for later review. Such capabilities make bed-based technology well suited to residential care facilities and supported-living environments. Europe is also seeing increasing adoption of connected wearables, making the region a balanced market between established Bed Sensor technologies and newer smartphone-linked systems.

Asia-Pacific

Asia-Pacific accounts for approximately 19% of current market demand but is projected to grow fastest at approximately 16.2% annually. The region contains a substantial proportion of the world's epilepsy population and includes highly developed digital-health markets such as Japan, South Korea, Australia, and Singapore alongside rapidly expanding healthcare systems in China, India, and Southeast Asia. Smartphone adoption creates favorable conditions for connected seizure-monitoring platforms.

The long-term opportunity is particularly large because approximately 80% of the world's more than 50 million people with epilepsy live in low- and middle-income countries, many of which are located in Asia. Online distribution can help overcome geographic barriers by providing access outside large metropolitan areas. However, affordability remains important, encouraging demand for systems that use existing smartphones and require limited specialist infrastructure. Regional growth is expected to be led by Wearable Devices as manufacturing scale reduces sensor costs and software platforms become available in more languages.

Middle East & Africa

The Middle East & Africa account for approximately 5% of current market demand but contain substantial unmet long-term potential. Epilepsy incidence can reach approximately 139 new diagnoses per 100,000 people annually in some low- and middle-income environments, compared with approximately 49 per 100,000 in high-income countries. Healthcare access remains uneven, making sophisticated home-monitoring equipment significantly less available than in North America or Europe.

Gulf countries provide the strongest near-term opportunities because of higher healthcare expenditure, connected-home adoption, and developed private medical systems. Africa presents a larger but more challenging long-term opportunity. Approximately three-quarters of people with epilepsy in low-income countries do not receive the treatment they need, highlighting the wider neurological-care gap. Monitoring technology cannot replace diagnosis or treatment, but lower-cost digital devices could become part of improving caregiver support as healthcare access expands. Online channels and smartphone-based Wearable Devices are expected to provide the most scalable route to broader availability.

List of Top Epileptic Seizure Monitor Alarm System Companies

• Empatica (US)
• Emfit (Finland)
• Alert-it (Denmark)
• Vahlkamp (Germany)
• Danish Care (Denmark)

Top 2 Companies Market Share

Empatica: Empatica is estimated to represent approximately 21% of competitive activity among the supplied companies, supported by its medical-grade wearable platform, smartphone integration, algorithm development, and clinical validation. Its current seizure-monitoring system is designed for users aged 6 years and older and incorporates motion and electrodermal activity sensing to identify patterns associated with defined generalized tonic-clonic seizures. The platform has demonstrated approximately 98% detection accuracy under validated conditions and provides up to 7 days of wearable battery life. Automated caregiver alerts, manual alert functionality, sleep information, activity tracking, and digital seizure diaries strengthen the company's competitive positioning within the rapidly growing Wearable Devices segment.

Emfit: Emfit is estimated to account for approximately 17% of competitive activity among the supplied companies, supported by decades of experience in contact-free sensing and under-mattress monitoring. The company's seizure-monitor development originated in approximately 2001 and has since become an established application of its force and movement-sensing technology. Emfit sensor technology has been cited in more than 100 research publications across broader biosignal applications, demonstrating a longstanding technical foundation. Together, Empatica and Emfit represent an estimated 38% of competitive activity among the supplied companies, while Alert-it, Vahlkamp, Danish Care, and other specialist manufacturers compete through bed sensors, care alarms, telecare integration, and institutional monitoring products.

Investment Analysis

Investment in the Epileptic Seizure Monitor Alarm System Market is increasingly directed toward wearable biosensors, artificial intelligence, mobile software, low-power electronics, battery optimization, and remote caregiver connectivity. Wearable Devices account for approximately 59% of demand and provide opportunities for recurring digital services in addition to hardware sales. A device operating for approximately 7 days between charges can collect continuous physiological and motion information while reducing interruptions associated with frequent charging. Developers are also investing in algorithms that combine more than 1 sensing modality because movement alone may not provide sufficient specificity in every environment. Clinical validation remains a major investment requirement, particularly when manufacturers seek medical-device authorization rather than positioning products as general wellness technologies.

Bed Sensor technology offers a separate investment opportunity centered on professional care, long-term durability, nurse-call integration, and false-alarm reduction. Established products have surpassed approximately 10,000 installed units, demonstrating that contact-free systems can maintain commercial demand even as wearable technology advances. Care homes and supported-living environments value systems capable of integrating multiple sensors and communicating over distances approaching 450 meters. Investment opportunities also exist in Asia-Pacific, where market demand is projected to grow approximately 16.2% annually. Manufacturers capable of reducing hardware costs while retaining reliable algorithms could address portions of the nearly 40 million people with epilepsy living in low- and middle-income countries.

New Product Development

New product development is increasingly focused on multisensor wearables capable of combining physiological and movement information within a single wrist-worn device. Current technology uses accelerometry and electrodermal activity to identify patterns associated with generalized tonic-clonic seizures while communicating through a paired smartphone. Detection accuracy reaching approximately 98% for defined monitored events demonstrates the potential of combining sensors and software rather than relying on movement alone. Development priorities include extending battery life beyond the current approximately 7-day benchmark, improving algorithm personalization, lowering false-alarm rates, reducing device size, strengthening cybersecurity, and increasing compatibility with multiple smartphone operating systems. Future products may also integrate additional physiological signals as long as added sensing does not compromise comfort or battery duration.

Bed Sensor development is centered on improved signal processing and multipurpose home-care integration. Current systems can combine movement sensing with sound, moisture, bed-vacation, breathing-related movement, and nurse-call functionality. Some monitors can retain approximately 20 event records, while others provide approximately 15 hours of backup battery capability in the event of power interruption. Product developers are increasingly seeking to distinguish clinically relevant repetitive movement from ordinary sleep behavior through adaptive sensitivity and digital filtering. Future systems may use wireless connectivity to transfer nighttime events into the same digital diary used by wearable products, creating combined 24-hour monitoring ecosystems rather than separate daytime and nighttime solutions.

Five Recent Developments

• February 2024: A next-generation wrist-worn epilepsy monitoring system received U.S. regulatory clearance for adults and children aged 6 years and older, strengthening medical-grade adoption of connected Wearable Devices for home and healthcare monitoring.
• February 2025: Wearable seizure-monitoring technology increasingly shifted toward longer-duration hardware, with current-generation platforms offering up to approximately 7 days of battery operation while maintaining smartphone-based automated caregiver alert functionality.
• June 2025: Updated U.S. regulatory review confirmed continued development of physiological signal-based seizure monitoring, reinforcing systems that combine wrist-worn motion and electrodermal sensing with paired mobile applications and remote caregiver alerts.
• January 2026: Professional Bed Sensor suppliers expanded updated guidance and support for systems incorporating seizure movement, bed-vacation, sound, moisture, telecare, and nurse-call functions, with selected radio products operating across approximately 450 meters.
• July 2026: Digital seizure monitoring increasingly emphasized validated multisensor algorithms, with leading wearable systems continuing to report approximately 98% detection accuracy for defined generalized tonic-clonic seizure monitoring compared with clinical reference measurement.

Report Coverage

The Epileptic Seizure Monitor Alarm System Market assessment covers industry conditions across the 2026-2035 forecast period and evaluates the 2 supplied product types and 2 supplied applications. Product segmentation includes Bed Sensor systems with approximately 41% market share and Wearable Devices with approximately 59%. Application analysis covers Online distribution at approximately 57% and Offline distribution at 43%. Geographic coverage includes North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, with North America holding approximately 38% of current demand and Asia-Pacific projected to expand at approximately 16.2% annually. Technical coverage includes under-mattress movement sensing, wrist-worn accelerometry, electrodermal activity, smartphone connectivity, caregiver alerts, radio communication, battery performance, false-alarm management, and remote monitoring.

The competitive assessment covers the 5 supplied companies: Empatica, Emfit, Alert-it, Vahlkamp, and Danish Care. Analysis considers wearable technology, contact-free Bed Sensor systems, digital algorithms, caregiver communication, telecare integration, clinical validation, battery performance, distribution strategy, and connected software. Current market conditions are supported by a global epilepsy population exceeding 50 million people, approximately 5 million new diagnoses annually, medical-grade wearable accuracy reaching approximately 98% for defined generalized tonic-clonic events, battery duration reaching around 7 days, professional radio monitoring ranges approaching 450 meters, and established bed-monitor product bases exceeding 10,000 units. Coverage also evaluates the transition toward connected monitoring ecosystems that combine hardware, smartphone applications, automated alerts, digital diaries, and caregiver communication through 2035.